Article

Preclinical efficacy of bacosides-lauric acid nano-herbal formulation in comparison to rivastigmine for treatment of Alzheimer’s disease

2022-06-29

Abstract excerpt

Despite decades of rigorous scientific endeavors for Alzheimer’s disease (AD) drug development, massive failures in clinical trials is continuously posing healthcare and societal burden. Currently recommended single targeted drugs including rivastigmine with limited bioavailability can alleviate AD symptoms only for a limited period of time but unable to reverse the disease progression. Recent evidences consider p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dca5134f-279b-5457-8f11-5fbc2cc74e28
DOI: 10.1101/2022.06.25.497622

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Preclinical efficacy of bacosides-lauric acid nano-herbal formulation in comparison to rivastigmine for treatment of Alzheimer’s diseaseDOI 10.1101/2022.06.25.497622Read

Exploring the therapeutic potential of natural compounds for Alzheimer's disease: Mechanisms of action and pharmacological propertiesSemantic proximity Read

Biologics as Therapeutical Agents Under Perspective Clinical Studies for Alzheimer’s DiseaseSemantic proximity Read

Curcumin in Alzheimer’s Disease: From Mechanistic Insights to Translational Challenges and Emerging Curcuminoid StrategiesSemantic proximity Read

Tau-Targeting Nanoparticles for Treatment of Alzheimer's DiseaseSemantic proximity Read

Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases.Semantic proximity Read

Efficacy of Curcumin in Neurodegenerative Diseases: From Pharmacokinetic Barriers to Advanced Delivery SystemsSemantic proximity Read

Isobavachalcone ameliorates Alzheimer disease pathology by autophagy-mediated clearance of amyloid beta and inhibition of NLRP3 inflammasome in 5XFAD miceSemantic proximity Read

An In Vivo C57BL/6 Mouse Study Demonstrating Fine-Tuning of Serum and Brain-Derived Exosomes Reveal Therapeutic Potential of Phytochemical Ferulic Acid Against Alzheimer’s DiseaseSemantic proximity Read

Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative DiseasesSemantic proximity Read

Nanotechnology Therapy for Alzheimer's Disease Memory Impairment Attenuation.Semantic proximity Read

Carprofen alleviates Alzheimer-like phenotypes of 5XFAD transgenic mice by targeting the pathological hallmarks induced by amyloid-β aggregationSemantic proximity Read

Advancements in Nanomedicine for Neurodegenerative Diseases: A Comprehensive ReviewSemantic proximity Read